Trial intelligence / Profile preview

Delmopinol for peri-implant mucositis treatment

NL-OMON26876Active, not recruiting

Sponsor
Academic Centre for Dentistry in Amsterdam
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Trial of delmopinol and chlorhexidine in peri-implant mucositis (3 arms), sponsored by Academic Centre for Dentistry in Amsterdam. Primary endpoint: Change in bleeding on probing. Started Sep 2015; status: active, not recruiting.

02

Drugs

delmopinolchlorhexidine
03

Conditions

peri-implant mucositis

Beyond the preview

Go deeper on NL-OMON26876.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26876.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call